Penn State Health

The Medical Minute: The three types of COVID-19 tests

22-Oct-2020 8:10 AM EDT, by Penn State Health

Newswise — Eight months into the COVID-19 pandemic, questions about testing abound. With COVID-19 cases trending upward, it’s important to understand when individuals should seek getting tested and what type of test they should have.

Currently, there are three different types of tests to determine whether someone has COVID-19 or has previously been infected. The molecular test, also known as the PCR — short for polymerase chain reaction — is considered to be the most accurate in detecting viral particles. Although samples for the molecular test can be collected from saliva, a nasal swab inserted far back in the nostril — a procedure called a nasopharyngeal swab — remains the preferred way to collect samples.

“The sensitivity of the test is much better when you get that deeper specimen,” said Dr. Catharine Paules, an infectious diseases physician at Penn State Health Milton S. Hershey Medical Center. “Even though it's uncomfortable, that's the best way to get the test done.”

Another way to diagnose COVID-19 is with antigen testing, which identifies viral proteins in a sample, often obtained from a swab of the lower portion of the nostril or from the deeper, nasopharyngeal swab.

“These are more likely to be point-of-care tests performed on plastic card-based assays, similar to a pregnancy test where a line will show up if it’s positive for the virus,” said Dr. Melissa George, interim chair of the Department of Pathology at the Milton S. Hershey Medical Center. “But right now, only a few antigen tests have received FDA emergency use authorization, and they’re only available in small volumes.” This method is also not as sensitive as molecular tests.

A third type of test does not look for active infection, but rather for evidence — through antibodies present — that someone has had COVID-19 in the past.

Which tests are best?

If someone is concerned that they might have COVID-19, the best type of test is the nasal swab with the molecular testing, explained Paules. “That will show if you’re actively infected with the virus.”

Point-of-care molecular tests that take 15 to 30 minutes to be processed may be available at some physician offices. But because of their lower sensitivity and higher false negative rates, both Paules and George recommend tests that are processed in a laboratory. Physicians can provide patients with lab orders for the test.

Some organizations use molecular tests from saliva samples for surveillance testing efforts. These involve taking a random sample of a percentage of a particular population, such as a university’s student body, in an attempt to identify asymptomatic individuals who might have COVID-19 and could be infectious.

“If a positive individual is identified, contact tracing and appropriate follow-up can occur to potentially contain an outbreak,” George said.

The saliva is collected by spitting in a funnel test tube, usually while a medical provider is watching from a video link to make sure that enough sample is provided.

“As more data become available, saliva testing may start to be used more commonly in clinical — as opposed to just surveillance — situations,” George said.

Presently, the recommendations for when to use antibody tests are limited.

“We're mostly using them to help us define clinical syndromes that might occur after COVID-19,” Paules said. “For example, multisystem inflammatory syndrome. It’s a serious inflammatory complication of COVID in children. One of the ways that we’ve been able to discover that and diagnose patients with it is through an antibody test.”

As far as considering the results of an antibody test to be a clean bill of health from future COVID infections, Paules advised against that.

“There’s a lot we still need to learn about the virus,” Paules said. “We need to learn if infection protects against reinfection down the road. And if it does, are antibodies the way that we measure that protection? Even if I went and had a positive antibody test today, that would not inspire me to change any of my behaviors. I would still wear a mask. I would still social distance.”

Waiting while isolating

The turnaround time for test results varies depending on the condition of the person getting tested, George said. Hospitalized patients who are tested generally will get results the same day. For outpatients, the results may take up to several days. And because the need for surveillance testing results is not urgent, those results often take several days.  

If the demand for testing grows this fall and winter, the turnaround time for results may increase, regardless of the testing type, explained George.

While awaiting test results, it’s essential to continue to isolate.

“If you had some cold-like symptoms — you’re coughing, you have a fever — and you got a test, your next step should be to go home and keep to yourself until that test result comes back negative,” Paules said. “You don't want to infect anyone else while you're waiting for those results.”

Learn more:

The Medical Minute is a weekly health news feature produced by Penn State Health. Articles feature the expertise of faculty, physicians and staff, and are designed to offer timely, relevant health information of interest to a broad audience.

Filters close

Showing results

110 of 4146
Newswise: Long-Term Impacts of COVID-19: Your Mental Health
Released: 25-Nov-2020 2:15 PM EST
Long-Term Impacts of COVID-19: Your Mental Health

The COVID-19 pandemic has shaped more than half a year of our lives, canceling plans, upending livelihoods and causing feelings of grief, stress and anxiety. And Cedars-Sinai mental health experts say the pandemic could be shaping our mental health well into the future.

Released: 25-Nov-2020 12:45 PM EST
SARS-CoV-2 mutations do not appear to increase transmissibility
University College London

None of the mutations currently documented in the SARS-CoV-2 virus appear to increase its transmissibility in humans, according to a study led by UCL researchers.

Newswise: COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
Released: 25-Nov-2020 11:05 AM EST
COVID-19 vaccine candidate tested preclinically at UAB nears first clinical test in people
University of Alabama at Birmingham

Maryland-based Altimmune Inc., a clinical stage biopharmaceutical company, has submitted an Investigational New Drug, or IND, application to the United States Food and Drug Administration to commence a Phase 1 clinical study of its single-dose intranasal COVID-19 vaccine candidate, AdCOVID.

Released: 25-Nov-2020 11:05 AM EST
BIDMC researchers reveal how genetic variations are linked to COVID-19 disease severity
Beth Israel Lahey Health

New research BIDMC-led sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.

Newswise: blog-pandemic-scenario-planning-lg-feature2.jpg
Released: 25-Nov-2020 11:05 AM EST
Pandemic Ups Game on Scenario Planning in The Arts
Wallace Foundation

Researcher/Author of new toolkit and report seeks to help arts and culture organizations add scenario planning to their strategic toolbox

Released: 25-Nov-2020 10:30 AM EST
Young people's anxiety levels doubled during first COVID-19 lockdown, says study
University of Bristol

The number of young people with anxiety doubled from 13 per cent to 24 per cent, during the early stages of the COVID-19 pandemic and lockdown 1, according to new research from the University of Bristol.

Newswise: 249837_web.jpg
Released: 25-Nov-2020 10:20 AM EST
Tracking COVID-19 trends in hard-hit states
Louisiana State University

Currently, there are over 10 million confirmed cases and more than 240,000 casualties attributed to COVID-19 in the U.S.

Released: 25-Nov-2020 9:55 AM EST
More Health Systems Join National #MaskUp Campaign
Cleveland Clinic

Many more health systems are joining the national #MaskUp campaign encouraging Americans to stop the spread of COVID-19 by following safety guidelines. Over just a few days, another 19 health systems with hundreds of hospitals united with 100 health systems nationwide with hospitals numbering in the thousands. The public service campaign is critical to the health and well-being of all Americans. It is a plea from healthcare professionals everywhere: wear a mask and follow other precautions to save lives and help get our country back on its feet.

Newswise: delaterre_jpeg.jpg
Released: 25-Nov-2020 7:35 AM EST
Warwick scientists design model to predict cellular drug targets against Covid-19
University of Warwick

The covid-19 virus, like all viruses relies on their host for reproduction

access_time Embargo lifts in 2 days
Embargo will expire: 30-Nov-2020 10:00 AM EST Released to reporters: 24-Nov-2020 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 30-Nov-2020 10:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Showing results

110 of 4146